What does the evidence say about cognitive behavioural therapy for adult ADHD?

Trials test structured, ADHD-focused therapy packages

Research findings apply to the programmes tested, not every therapy carrying the CBT label. ADHD-focused CBT combines practical behaviour changes with work on unhelpful thinking patterns. Safren's trial package included planning, managing distractions and procrastination, with repeated practice and review. (jamanetwork.com)

When a programme cites research, use these questions to check how closely the evidence matches what you are considering:

• Who took part: adults with diagnosed ADHD or people reporting attention difficulties?
• What did the comparison group receive: a waiting list, usual care or scheduled supportive sessions?
• What changed: ADHD symptom ratings, daily functioning or quality of life?
• When was progress measured: at treatment completion or after sessions had stopped?

Ask for the programme's content and intended outcomes, not just its label. You do not need to interpret every statistic yourself. A useful discussion connects the research to the difficulties you want to address.

This page explains research. It does not diagnose ADHD or replace an individual discussion with a qualified clinician.

Cochrane results depend on the comparison treatment

The review supports short-term symptom benefits, but not consistently against supportive therapy. Lopez and colleagues' 2018 Cochrane review included 14 randomised trials and 700 adults. Searches ended in June 2017. (cochrane.org)

Cochrane downgraded confidence because of small samples, inconsistency and study limitations. These grades describe its evidence at that time. (cochrane.org)

A standardised effect puts results from different scales onto a shared scale. In this table, negative values favour CBT. These numbers are not percentages or personal chances of improvement. (pubmed.ncbi.nlm.nih.gov)

Active-comparison trials did not all show a CBT advantage

Individual trials do not all point in the same direction. Their treatment formats and comparison groups differ, so a positive trial and an unclear result can both be informative. (jamanetwork.com)

Safren trial: individual CBT added to existing care

In Safren and colleagues' JAMA trial (2010), 86 US adults with persistent ADHD symptoms despite medication were randomised to 12 individual CBT sessions or relaxation with educational support. Therapist contact was matched. An assessor unaware of the assigned therapy rated symptoms. (jamanetwork.com)

Using at least a 30% symptom reduction to define response, 67% responded with CBT versus 33% with the comparison treatment. This supported adding that package, not stopping medication. (jamanetwork.com)

COMPAS trial: group CBT versus individual clinical management

Philipsen and colleagues' COMPAS trial, published in JAMA Psychiatry (2015), randomised 433 German adults, with 419 included in the analysis. It compared CBT-based group psychotherapy with individual clinical management. Medication or placebo was assigned separately. (jamanetwork.com)

At three months, masked ratings on the ADHD Index averaged 17.6 with group therapy and 16.5 with clinical management. The roughly one-point difference favoured management numerically but was not statistically clear. This trial did not establish an added benefit on its primary symptom outcome. (jamanetwork.com)

For readers, the useful question is not which headline sounds encouraging. Ask whether the trial's format, participants and comparison treatment resemble the proposed therapy.

For anyone taking medication, potential benefits and unwanted effects still need review with their prescribing clinician. (caddra.ca)

Newer reviews separate symptoms from daily functioning

Symptom relief and changes in daily life need separate assessment, and recent reviews have examined both. (pubmed.ncbi.nlm.nih.gov)

Ostinelli and colleagues' review in The Lancet Psychiatry (Elsevier, 2025) analysed 113 randomised trials involving 14,887 diagnosed adults across several treatments, not just CBT. At about 12 weeks, its network estimate favoured CBT over placebo on clinician-rated ADHD symptoms: effect −0.76, a moderate-to-large difference. Self-ratings did not show a clear advantage. (pubmed.ncbi.nlm.nih.gov)

A network analysis combines direct comparisons with estimates linked through other trials. Its total participant count must not be presented as though everyone received CBT. (pubmed.ncbi.nlm.nih.gov)

López-Pinar and colleagues' Behaviour Research and Therapy review (2026) included 70 studies and 5,152 participants: 38 randomised trials, plus other controlled and uncontrolled studies. Packages varied, and not all adults had diagnosed ADHD. (sciencedirect.com)

Across 16 controlled studies with 1,164 participants, ratings of overall daily functioning favoured CBT over varied active and inactive controls: effect 0.47, a moderate difference. Quality-of-life benefits were small at treatment completion, effect 0.28, with no clear benefit at follow-up, effect 0.18. (sciencedirect.com)

The authors graded the controlled global-functioning evidence as high certainty. However, follow-up was typically about three months, and many outcomes relied on self-report. That limits claims about lasting change. (sciencedirect.com)

For a therapy discussion, keep separate questions on the page: are symptoms changing, are daily tasks becoming manageable, and is life feeling different in a way that matters? Decide with the therapist which outcomes will be tracked.

What the evidence does not show

These studies cannot predict your personal result, isolate every useful ingredient or establish that benefits will last indefinitely. (pubmed.ncbi.nlm.nih.gov)

• Duration: Safren's follow-up mainly tracked CBT responders. Gains persisted at 12 months from baseline, about nine months after treatment. That is not evidence of permanent benefit. (jamanetwork.com)
• Specific ingredients: package-level findings do not establish that a planner, worksheet or individual exercise produces the same effect when used alone. (sciencedirect.com)
• Rating bias: participants know which psychological treatment they receive. Differences in expectations may influence scores, even when outcome assessors do not know the treatment assignment. (jamanetwork.com)
• Complete safety: Cochrane found no reported serious adverse events, but harms data were limited. Absence of reports does not establish that therapy is risk-free. (cochrane.org)

When comparing reviews, check for repeated studies rather than adding their sample sizes together.

Before starting, ask what would count as useful progress and when you will review it. If there is no change, you do not need to interpret that as a personal failure. Discuss fit, pace, practice demands and whether a different plan is needed.

Include the burden of attendance and practice in that review, not only the symptom score. Ask what can be adjusted if the work between sessions feels unmanageable.

How this applies in Canada

Canadian guidance recognises ADHD-focused CBT as an adult treatment option. CADDRA's Canadian ADHD Practice Guidelines, edition 4.1 (2020), emphasise time management and organisation. This is clinical guidance, not a Canadian randomised trial or a measured success rate for any clinic. (caddra.ca)

To put the evidence into a practical discussion, consider these questions for a therapist:

1. Ask which adult ADHD CBT manual or structured approach they use. Which parts resemble a studied programme, and which parts will be adapted to your needs?
2. Agree on a practical target, such as beginning planned tasks or remembering commitments. Ask what information will be recorded at the outset so you can review change.
3. Ask how practice between sessions will be planned and reviewed. If written exercises are difficult to follow, discuss an accessible alternative rather than leaving the difficulty unspoken.
4. Agree when to review progress and unwanted effects. Ask how you will decide whether to continue, adjust the approach or reconsider the treatment plan.

Before committing, clarify the proposed course length and what happens if sessions are missed. You can also ask how the therapist distinguishes a change in questionnaire scores from a change that matters in your daily life.

If you plan to use extended health benefits, check your plan with your insurer, including eligible provider designations and service requirements. Do not assume a guideline recommendation determines reimbursement.

Finding Focus's CBT service is provided by a Registered Social Worker for adults 18+ physically located in Ontario only. The research above is not measured outcome data from Finding Focus. The therapist does not diagnose ADHD, prescribe or adjust medication, conduct psychological testing, or write third-party reports. Medication questions should go to the prescribing clinician.